Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Angioplasty, Balloon, Coronary | 39 | 2013 | 1873 | 1.660 |
Why?
|
Drug-Eluting Stents | 19 | 2015 | 753 | 0.940 |
Why?
|
Osteoarthritis, Knee | 10 | 2023 | 1222 | 0.850 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 14 | 2016 | 314 | 0.760 |
Why?
|
Stents | 20 | 2015 | 3280 | 0.590 |
Why?
|
Registries | 38 | 2016 | 8089 | 0.530 |
Why?
|
Arthroplasty, Replacement, Knee | 7 | 2023 | 1458 | 0.480 |
Why?
|
Obesity, Morbid | 6 | 2023 | 1213 | 0.440 |
Why?
|
Coronary Artery Disease | 20 | 2016 | 6487 | 0.430 |
Why?
|
Bariatric Surgery | 6 | 2021 | 952 | 0.410 |
Why?
|
Coronary Disease | 14 | 2012 | 6077 | 0.380 |
Why?
|
Gastric Bypass | 4 | 2023 | 812 | 0.370 |
Why?
|
Exercise Therapy | 3 | 2019 | 906 | 0.290 |
Why?
|
Myocardial Infarction | 25 | 2016 | 11727 | 0.290 |
Why?
|
Myocardial Revascularization | 6 | 2012 | 841 | 0.290 |
Why?
|
Menopause | 7 | 2016 | 1626 | 0.270 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2009 | 2104 | 0.270 |
Why?
|
Carotid Artery Diseases | 3 | 2014 | 882 | 0.250 |
Why?
|
Catastrophization | 2 | 2020 | 316 | 0.250 |
Why?
|
Coronary Vessels | 5 | 2014 | 3107 | 0.230 |
Why?
|
Spondylarthritis | 1 | 2024 | 62 | 0.220 |
Why?
|
Spondylitis, Ankylosing | 1 | 2024 | 156 | 0.210 |
Why?
|
Diabetes Complications | 6 | 2021 | 1359 | 0.200 |
Why?
|
Women's Health | 4 | 2016 | 2034 | 0.200 |
Why?
|
Pain Measurement | 4 | 2020 | 3420 | 0.200 |
Why?
|
Vasomotor System | 2 | 2012 | 209 | 0.190 |
Why?
|
Hot Flashes | 3 | 2012 | 317 | 0.190 |
Why?
|
Coronary Restenosis | 7 | 2013 | 424 | 0.190 |
Why?
|
Uveitis | 1 | 2024 | 375 | 0.180 |
Why?
|
Preoperative Period | 3 | 2020 | 549 | 0.180 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2019 | 44 | 0.170 |
Why?
|
Middle Aged | 72 | 2021 | 213383 | 0.170 |
Why?
|
Metals | 6 | 2015 | 719 | 0.170 |
Why?
|
Diabetes Mellitus | 8 | 2021 | 5751 | 0.170 |
Why?
|
Knee Injuries | 1 | 2023 | 490 | 0.160 |
Why?
|
Treatment Outcome | 40 | 2021 | 63114 | 0.160 |
Why?
|
Laparoscopy | 3 | 2022 | 2151 | 0.160 |
Why?
|
Coronary Stenosis | 3 | 2011 | 834 | 0.160 |
Why?
|
Clubfoot | 1 | 2019 | 63 | 0.160 |
Why?
|
Coronary Angiography | 13 | 2014 | 4577 | 0.150 |
Why?
|
Aortic Diseases | 1 | 2004 | 742 | 0.150 |
Why?
|
Aged | 57 | 2021 | 163280 | 0.150 |
Why?
|
Female | 85 | 2021 | 380194 | 0.140 |
Why?
|
United States | 39 | 2021 | 69872 | 0.140 |
Why?
|
Weight Loss | 4 | 2023 | 2622 | 0.140 |
Why?
|
Follicle Stimulating Hormone | 2 | 2015 | 744 | 0.130 |
Why?
|
Male | 73 | 2021 | 350118 | 0.130 |
Why?
|
Renal Insufficiency | 2 | 2016 | 804 | 0.130 |
Why?
|
Carotid Arteries | 2 | 2014 | 952 | 0.130 |
Why?
|
Risk Factors | 32 | 2019 | 72290 | 0.130 |
Why?
|
Gastroplasty | 2 | 2016 | 142 | 0.130 |
Why?
|
Follow-Up Studies | 22 | 2021 | 39050 | 0.120 |
Why?
|
Humans | 95 | 2024 | 744343 | 0.120 |
Why?
|
Osteoarthritis | 1 | 2021 | 1036 | 0.110 |
Why?
|
Angina, Unstable | 2 | 2009 | 926 | 0.110 |
Why?
|
Prescriptions | 1 | 2016 | 387 | 0.110 |
Why?
|
Hospital Mortality | 13 | 2012 | 5317 | 0.110 |
Why?
|
Aorta | 1 | 2001 | 2061 | 0.110 |
Why?
|
Compression Bandages | 1 | 2012 | 15 | 0.110 |
Why?
|
Cardiovascular Agents | 3 | 2016 | 850 | 0.110 |
Why?
|
Hemorrhage | 2 | 2016 | 3461 | 0.110 |
Why?
|
Prosthesis Design | 7 | 2014 | 2110 | 0.110 |
Why?
|
Coronary Circulation | 2 | 2010 | 1572 | 0.100 |
Why?
|
Proportional Hazards Models | 13 | 2013 | 12354 | 0.100 |
Why?
|
Range of Motion, Articular | 1 | 2018 | 1578 | 0.100 |
Why?
|
Prospective Studies | 21 | 2020 | 53288 | 0.100 |
Why?
|
Retreatment | 5 | 2011 | 610 | 0.100 |
Why?
|
Arthralgia | 1 | 2015 | 456 | 0.100 |
Why?
|
Coronary Aneurysm | 1 | 2013 | 237 | 0.100 |
Why?
|
Vascular Diseases | 2 | 2013 | 1161 | 0.100 |
Why?
|
Disability Evaluation | 1 | 2018 | 1827 | 0.100 |
Why?
|
Binge-Eating Disorder | 1 | 2012 | 137 | 0.090 |
Why?
|
Blood Flow Velocity | 3 | 2005 | 1423 | 0.090 |
Why?
|
Consensus | 1 | 2019 | 2959 | 0.090 |
Why?
|
Time Factors | 19 | 2016 | 40075 | 0.090 |
Why?
|
Academies and Institutes | 1 | 2012 | 317 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1643 | 0.090 |
Why?
|
Coronary Artery Bypass | 9 | 2011 | 2289 | 0.090 |
Why?
|
Exercise Tolerance | 1 | 2014 | 770 | 0.090 |
Why?
|
Drug Utilization | 1 | 2016 | 1183 | 0.090 |
Why?
|
Chi-Square Distribution | 6 | 2012 | 3508 | 0.090 |
Why?
|
beta 2-Glycoprotein I | 1 | 2009 | 28 | 0.090 |
Why?
|
Patient Compliance | 2 | 2018 | 2684 | 0.090 |
Why?
|
Telemetry | 1 | 2010 | 205 | 0.090 |
Why?
|
Comorbidity | 9 | 2018 | 10388 | 0.080 |
Why?
|
Prescription Drugs | 1 | 2016 | 595 | 0.080 |
Why?
|
Pain | 3 | 2023 | 4986 | 0.080 |
Why?
|
Hemostasis | 1 | 2011 | 458 | 0.080 |
Why?
|
Patient Discharge | 2 | 2016 | 3313 | 0.080 |
Why?
|
Diabetic Angiopathies | 2 | 2011 | 818 | 0.080 |
Why?
|
Gastrectomy | 2 | 2023 | 663 | 0.080 |
Why?
|
Motor Activity | 1 | 2018 | 2714 | 0.080 |
Why?
|
Obesity | 5 | 2023 | 12745 | 0.080 |
Why?
|
After-Hours Care | 1 | 2008 | 102 | 0.080 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3610 | 0.080 |
Why?
|
Sex Factors | 7 | 2011 | 10397 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2016 | 3068 | 0.070 |
Why?
|
Sweating | 3 | 2012 | 123 | 0.070 |
Why?
|
Severity of Illness Index | 9 | 2020 | 15540 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 550 | 0.070 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2010 | 386 | 0.070 |
Why?
|
Tunica Intima | 2 | 2013 | 464 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2418 | 0.070 |
Why?
|
Lipoproteins | 1 | 2012 | 878 | 0.070 |
Why?
|
Survival Rate | 9 | 2013 | 12788 | 0.070 |
Why?
|
Arteriosclerosis | 2 | 2004 | 1092 | 0.070 |
Why?
|
Computer Systems | 1 | 2008 | 483 | 0.070 |
Why?
|
Kidney Failure, Chronic | 2 | 2011 | 2538 | 0.070 |
Why?
|
Iliac Aneurysm | 1 | 2006 | 38 | 0.070 |
Why?
|
Arterial Occlusive Diseases | 1 | 2011 | 793 | 0.070 |
Why?
|
Age Factors | 10 | 2016 | 18370 | 0.070 |
Why?
|
Blood Transfusion | 2 | 2016 | 1301 | 0.070 |
Why?
|
Risk Assessment | 10 | 2016 | 23338 | 0.070 |
Why?
|
Insulin | 3 | 2012 | 6580 | 0.070 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2006 | 1390 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 6 | 2013 | 6538 | 0.070 |
Why?
|
Osteoporotic Fractures | 1 | 2010 | 401 | 0.060 |
Why?
|
Recurrence | 5 | 2019 | 8340 | 0.060 |
Why?
|
Heart Failure | 4 | 2011 | 10900 | 0.060 |
Why?
|
Cause of Death | 3 | 2011 | 3584 | 0.060 |
Why?
|
Monitoring, Ambulatory | 1 | 2008 | 355 | 0.060 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2011 | 531 | 0.060 |
Why?
|
Telephone | 1 | 2008 | 617 | 0.060 |
Why?
|
Creatinine | 2 | 2007 | 1919 | 0.060 |
Why?
|
Thrombosis | 3 | 2013 | 2968 | 0.060 |
Why?
|
Longitudinal Studies | 6 | 2021 | 13989 | 0.060 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2005 | 205 | 0.060 |
Why?
|
Collateral Circulation | 1 | 2005 | 287 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4215 | 0.060 |
Why?
|
Health Behavior | 1 | 2016 | 2636 | 0.060 |
Why?
|
Adult | 19 | 2021 | 214055 | 0.060 |
Why?
|
Triglycerides | 1 | 2012 | 2454 | 0.060 |
Why?
|
Aorta, Abdominal | 1 | 2007 | 646 | 0.060 |
Why?
|
Fibrinogen | 2 | 2011 | 894 | 0.060 |
Why?
|
Embolism | 1 | 2007 | 408 | 0.060 |
Why?
|
Remission Induction | 2 | 2021 | 2386 | 0.060 |
Why?
|
Stroke Volume | 4 | 2011 | 5007 | 0.050 |
Why?
|
Pulsatile Flow | 1 | 2004 | 332 | 0.050 |
Why?
|
Carotid Artery, Internal | 1 | 2005 | 445 | 0.050 |
Why?
|
Death, Sudden, Cardiac | 1 | 2011 | 1541 | 0.050 |
Why?
|
Angina Pectoris | 1 | 2006 | 977 | 0.050 |
Why?
|
Quality of Life | 4 | 2019 | 12804 | 0.050 |
Why?
|
Hematoma | 1 | 2007 | 758 | 0.050 |
Why?
|
Graft Occlusion, Vascular | 1 | 2005 | 549 | 0.050 |
Why?
|
Calcinosis | 1 | 2011 | 1499 | 0.050 |
Why?
|
Carotid Stenosis | 2 | 2009 | 854 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5615 | 0.050 |
Why?
|
Retrospective Studies | 15 | 2019 | 77449 | 0.050 |
Why?
|
Blood Glucose | 3 | 2012 | 6256 | 0.050 |
Why?
|
Mental Health | 1 | 2015 | 3019 | 0.050 |
Why?
|
Myocardial Ischemia | 2 | 2009 | 2148 | 0.050 |
Why?
|
Immunosuppressive Agents | 3 | 2012 | 4149 | 0.050 |
Why?
|
Minority Groups | 1 | 2008 | 1223 | 0.050 |
Why?
|
Linear Models | 3 | 2019 | 5952 | 0.050 |
Why?
|
Tomography, Optical Coherence | 1 | 2013 | 2657 | 0.050 |
Why?
|
Estradiol | 3 | 2012 | 2020 | 0.050 |
Why?
|
Blood Vessel Prosthesis | 1 | 2005 | 933 | 0.050 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 441 | 0.050 |
Why?
|
Medical Errors | 1 | 2008 | 1297 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2915 | 0.040 |
Why?
|
Postoperative Period | 2 | 2020 | 1842 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5391 | 0.040 |
Why?
|
Inpatients | 2 | 2009 | 2518 | 0.040 |
Why?
|
Venous Thromboembolism | 1 | 2012 | 1671 | 0.040 |
Why?
|
Risk Adjustment | 1 | 2003 | 594 | 0.040 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2886 | 0.040 |
Why?
|
Back Pain | 1 | 2024 | 545 | 0.040 |
Why?
|
Physical Therapy Modalities | 1 | 2023 | 550 | 0.040 |
Why?
|
Postoperative Complications | 6 | 2013 | 15295 | 0.040 |
Why?
|
Incidence | 7 | 2013 | 20947 | 0.040 |
Why?
|
Heart Transplantation | 1 | 2013 | 3110 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2015 | 3445 | 0.040 |
Why?
|
Musculoskeletal Manipulations | 1 | 2018 | 25 | 0.040 |
Why?
|
Hypoglycemic Agents | 2 | 2009 | 2872 | 0.040 |
Why?
|
Tenotomy | 1 | 2019 | 49 | 0.040 |
Why?
|
Elasticity | 1 | 2001 | 657 | 0.040 |
Why?
|
Odds Ratio | 5 | 2016 | 9849 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2012 | 3864 | 0.040 |
Why?
|
Benchmarking | 1 | 2005 | 1042 | 0.040 |
Why?
|
Braces | 1 | 2019 | 135 | 0.040 |
Why?
|
Patient Readmission | 1 | 2012 | 3114 | 0.040 |
Why?
|
Cohort Studies | 8 | 2016 | 40561 | 0.040 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2011 | 1813 | 0.040 |
Why?
|
Serum Albumin | 1 | 2001 | 676 | 0.040 |
Why?
|
Multicenter Studies as Topic | 2 | 2018 | 1677 | 0.040 |
Why?
|
Casts, Surgical | 1 | 2019 | 178 | 0.040 |
Why?
|
Models, Cardiovascular | 1 | 2003 | 996 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5867 | 0.040 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2007 | 1186 | 0.040 |
Why?
|
Anticoagulants | 1 | 2012 | 4599 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2008 | 2624 | 0.040 |
Why?
|
Haiti | 1 | 2019 | 553 | 0.040 |
Why?
|
Resistance Training | 1 | 2018 | 165 | 0.040 |
Why?
|
Aged, 80 and over | 9 | 2018 | 57776 | 0.040 |
Why?
|
Kidney | 2 | 2016 | 7186 | 0.040 |
Why?
|
Femoral Artery | 1 | 2001 | 845 | 0.040 |
Why?
|
Aging | 1 | 2015 | 8664 | 0.040 |
Why?
|
Coronary Thrombosis | 2 | 2011 | 495 | 0.040 |
Why?
|
Czech Republic | 1 | 2016 | 69 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3047 | 0.030 |
Why?
|
Glomerular Filtration Rate | 2 | 2016 | 2170 | 0.030 |
Why?
|
Canada | 2 | 2016 | 2065 | 0.030 |
Why?
|
Angioplasty | 2 | 2010 | 364 | 0.030 |
Why?
|
Efficiency | 1 | 2019 | 462 | 0.030 |
Why?
|
Length of Stay | 4 | 2012 | 6309 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2759 | 0.030 |
Why?
|
Life Tables | 2 | 2006 | 370 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2016 | 513 | 0.030 |
Why?
|
C-Reactive Protein | 2 | 2011 | 3778 | 0.030 |
Why?
|
Prognosis | 5 | 2018 | 29063 | 0.030 |
Why?
|
Smoking | 3 | 2011 | 8987 | 0.030 |
Why?
|
Health Services Accessibility | 2 | 2009 | 5137 | 0.030 |
Why?
|
C-Peptide | 1 | 2016 | 419 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 3255 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2010 | 1240 | 0.030 |
Why?
|
Predictive Value of Tests | 5 | 2012 | 15076 | 0.030 |
Why?
|
Contrast Media | 1 | 2007 | 5300 | 0.030 |
Why?
|
Electrocardiography | 1 | 2007 | 6442 | 0.030 |
Why?
|
Guideline Adherence | 2 | 2018 | 2266 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2010 | 7880 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2012 | 10943 | 0.030 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2278 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2010 | 1518 | 0.030 |
Why?
|
Hematopoietic Cell Growth Factors | 1 | 1993 | 102 | 0.030 |
Why?
|
Clinical Competence | 1 | 2008 | 4687 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2010 | 15519 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2011 | 12245 | 0.030 |
Why?
|
Tunica Media | 1 | 2013 | 113 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2012 | 8642 | 0.030 |
Why?
|
Follicle Stimulating Hormone, Human | 1 | 2012 | 25 | 0.030 |
Why?
|
Radiation-Protective Agents | 1 | 1993 | 90 | 0.030 |
Why?
|
Renal Dialysis | 2 | 2016 | 1786 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 9959 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 11725 | 0.030 |
Why?
|
Age Distribution | 2 | 2011 | 2902 | 0.030 |
Why?
|
Inflammation | 1 | 2011 | 10638 | 0.030 |
Why?
|
Body Mass Index | 3 | 2018 | 12720 | 0.020 |
Why?
|
Factor VII | 1 | 2011 | 139 | 0.020 |
Why?
|
Reward | 1 | 2018 | 941 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2021 | 2716 | 0.020 |
Why?
|
Regression Analysis | 1 | 2001 | 6459 | 0.020 |
Why?
|
Logistic Models | 3 | 2016 | 13408 | 0.020 |
Why?
|
Hospitalization | 5 | 2009 | 10262 | 0.020 |
Why?
|
Atherectomy, Coronary | 1 | 2011 | 148 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2010 | 17446 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2012 | 6489 | 0.020 |
Why?
|
Angiography | 2 | 2006 | 1639 | 0.020 |
Why?
|
Risk | 3 | 2011 | 9687 | 0.020 |
Why?
|
Hyperplasia | 1 | 2013 | 1185 | 0.020 |
Why?
|
Arthroscopy | 1 | 2016 | 926 | 0.020 |
Why?
|
Aspirin | 2 | 2012 | 3282 | 0.020 |
Why?
|
Insulin, Long-Acting | 1 | 2009 | 57 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2010 | 520 | 0.020 |
Why?
|
Interleukin-1 | 1 | 1993 | 1263 | 0.020 |
Why?
|
Research Design | 2 | 2019 | 5987 | 0.020 |
Why?
|
Models, Statistical | 1 | 2003 | 5102 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2012 | 624 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2009 | 300 | 0.020 |
Why?
|
Patient Care Team | 1 | 2019 | 2531 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2012 | 662 | 0.020 |
Why?
|
Nitrates | 1 | 2009 | 265 | 0.020 |
Why?
|
Motivation | 1 | 2018 | 1971 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.020 |
Why?
|
Preoperative Care | 1 | 2016 | 2250 | 0.020 |
Why?
|
Saphenous Vein | 1 | 2010 | 532 | 0.020 |
Why?
|
Product Labeling | 1 | 2008 | 79 | 0.020 |
Why?
|
Ticlopidine | 1 | 2012 | 899 | 0.020 |
Why?
|
Algorithms | 1 | 2007 | 13881 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15165 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 2012 | 894 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1637 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2009 | 690 | 0.020 |
Why?
|
Observation | 1 | 2008 | 312 | 0.020 |
Why?
|
North America | 1 | 2009 | 1249 | 0.020 |
Why?
|
Mood Disorders | 1 | 2012 | 1106 | 0.020 |
Why?
|
Lupus Nephritis | 1 | 2009 | 310 | 0.020 |
Why?
|
Hospital Records | 1 | 2005 | 95 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2016 | 2585 | 0.020 |
Why?
|
Prevalence | 2 | 2013 | 15226 | 0.020 |
Why?
|
Sirolimus | 1 | 2012 | 1564 | 0.020 |
Why?
|
Paclitaxel | 1 | 2012 | 1708 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2011 | 1261 | 0.020 |
Why?
|
Hypolipidemic Agents | 1 | 2009 | 604 | 0.020 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2008 | 501 | 0.020 |
Why?
|
Iliac Artery | 1 | 2006 | 364 | 0.020 |
Why?
|
Polysomnography | 1 | 2011 | 1776 | 0.020 |
Why?
|
Coronary Occlusion | 1 | 2007 | 304 | 0.020 |
Why?
|
Affect | 1 | 2012 | 1476 | 0.020 |
Why?
|
Survival Analysis | 2 | 2008 | 10252 | 0.020 |
Why?
|
Propensity Score | 1 | 2011 | 1781 | 0.010 |
Why?
|
Cost of Illness | 1 | 2013 | 1859 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
Vascular Patency | 1 | 2006 | 886 | 0.010 |
Why?
|
Hip Joint | 1 | 2010 | 1002 | 0.010 |
Why?
|
Area Under Curve | 1 | 2007 | 1654 | 0.010 |
Why?
|
Primary Health Care | 2 | 2010 | 4558 | 0.010 |
Why?
|
Venous Thrombosis | 1 | 2012 | 1239 | 0.010 |
Why?
|
Reproducibility of Results | 3 | 2007 | 19905 | 0.010 |
Why?
|
Workload | 1 | 2008 | 850 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5078 | 0.010 |
Why?
|
Haplotypes | 1 | 2009 | 2779 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7785 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3339 | 0.010 |
Why?
|
Home Care Services | 1 | 2008 | 606 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2010 | 1889 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3588 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2005 | 780 | 0.010 |
Why?
|
Shock, Cardiogenic | 1 | 2007 | 688 | 0.010 |
Why?
|
Collagen | 1 | 2010 | 2689 | 0.010 |
Why?
|
Hypoglycemia | 1 | 2009 | 861 | 0.010 |
Why?
|
Fatigue | 1 | 2008 | 1531 | 0.010 |
Why?
|
Homeostasis | 1 | 2012 | 3340 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2703 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2010 | 1848 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 2012 | 2690 | 0.010 |
Why?
|
Brachytherapy | 1 | 2008 | 1248 | 0.010 |
Why?
|
Blood Pressure | 2 | 2011 | 8554 | 0.010 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 641 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2009 | 1373 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 2007 | 1504 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4186 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6114 | 0.010 |
Why?
|
Incidental Findings | 1 | 2004 | 689 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2005 | 1206 | 0.010 |
Why?
|
Disease Management | 1 | 2010 | 2459 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2012 | 2376 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6933 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 25625 | 0.010 |
Why?
|
Equipment Design | 1 | 2007 | 3582 | 0.010 |
Why?
|
Echocardiography | 1 | 2011 | 5102 | 0.010 |
Why?
|
Sex Distribution | 1 | 2003 | 2297 | 0.010 |
Why?
|
Bone Density | 1 | 2010 | 3468 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2007 | 2158 | 0.010 |
Why?
|
Medical Records | 1 | 2002 | 1413 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35136 | 0.010 |
Why?
|
Lung Diseases | 1 | 2007 | 1886 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2373 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2006 | 1392 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 41006 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2007 | 2149 | 0.010 |
Why?
|
Genetic Testing | 1 | 2009 | 3444 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1993 | 9274 | 0.010 |
Why?
|
Reoperation | 1 | 2005 | 4201 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2219 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3843 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 2003 | 2161 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 3923 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2007 | 20129 | 0.010 |
Why?
|
Medicare | 1 | 2010 | 6566 | 0.010 |
Why?
|
Stem Cell Factor | 1 | 1993 | 219 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 1993 | 262 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9146 | 0.010 |
Why?
|
Phenotype | 1 | 2009 | 16365 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1993 | 876 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2009 | 21746 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1993 | 1827 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14722 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 1999 | 1855 | 0.010 |
Why?
|
Cholesterol | 1 | 1999 | 2917 | 0.010 |
Why?
|
Hypertension | 1 | 2008 | 8480 | 0.010 |
Why?
|
Disease Progression | 1 | 2004 | 13284 | 0.000 |
Why?
|
Lipopolysaccharides | 1 | 1993 | 2216 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1993 | 6622 | 0.000 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1993 | 4420 | 0.000 |
Why?
|
Neoplasms | 1 | 2009 | 21683 | 0.000 |
Why?
|
Mice | 1 | 1993 | 81183 | 0.000 |
Why?
|
Animals | 1 | 1993 | 168757 | 0.000 |
Why?
|